By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Meridian Bioscience's wholly owned subsidiary Bioline announced today that its illumigene Group B Streptococcus test has received regulatory approval for commercialization in Australia.

Clearance from the Therapeutic Goods Administration follows similar action in the US by the Food and Drug Administration.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Mary Beckerle has been removed as director of the Huntsman Cancer Institute in what one researcher refers to as a "coup," ScienceInsider reports.

Bill Gates tells the Telegraph that bioterrorism is a serious risk.

The March for Science is to take place tomorrow, and supporters are tapping their creative energies to create placards to carry.

CBS News reports that the White House Science Fair is to continue under President Donald Trump.